SCHEMBL6359249

SCHEMBL6359249

CN(C)c1ccc(-n2cc(Br)cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 6/20 0.40
MAPT P10636 5/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALOX15 P16050 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TSHR P16473 2/20 0.39
APP P05067 3/20 0.39
HPGD P15428 2/20 0.35
RAB9A P51151 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
PRKCI P41743 1/20 0.35
NPC1 O15118 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25900771 0.80 ALDH1A1 (0.46) MEN1KMT2AALDH1A1MAPTL3MBTL1
SCHEMBL671957 0.79 ELANE (0.49) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL18666368 0.76 ALDH1A1 (0.38) MEN1KMT2AALDH1A1MAPTL3MBTL1
SCHEMBL15008954 0.76 MEN1 (0.47) MEN1KMT2APKMALDH1A1L3MBTL1
SCHEMBL6360678 0.76 KMT2A (0.47) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL182108 0.76 MEN1 (0.47) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL23612174 0.75 KMT2A (0.43) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL11899706 0.75 SMN1; SMN2 (0.50) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL14128469 0.75 F2 (0.45) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL152495 0.75 GAA (0.59) MEN1KMT2APKMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050271584-A1 Biphenyls and fluorenes as imaging agents in alzheimer's disease THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050271584-A1 Biphenyls and fluorenes as imaging agents in alzheimer's disease APP, BACE2, BACE1 MEN1 665/4885KMT2A 3164/4885PKM 3972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.